3.237.91.98
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

FDA Alerts

FDA approves Tecvayli for previously treated relapsed/refractory multiple myeloma

The U.S. Food and Drug Administration has approved teclistamab-cqyv (Tecvayli) for the treatment of adult patients with relapsed or refractory multiple myeloma, who previously received ≥4 prior lines of therapy, including a proteasome inhibitor, immunomodulatory drug, and anti-CD38 monoclonal antibody. This indication is approved under accelerated approval based on response rate....

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-